Eiser C, Upton P
Department of Psychology, The University of Sheffield, Western Bank, Sheffield, UK.
Child Care Health Dev. 2007 Jul;33(4):455-9. doi: 10.1111/j.1365-2214.2006.00710.x.
Current therapies for childhood cancer have resulted in improved survival rates. However, this has been achieved at considerable price to families, with financial costs including additional expenditure and loss of earnings having been described. The impact of these extra costs for UK families and the extent to which help from charities and government benefits is able to alleviate this is unknown.
Questionnaires concerning income, expenditure, employment and financial support were completed by 145 parents, recruited from three United Kingdom Children's Cancer Study Group treatment centres.
Parents' responses highlighted increased expenditure related mainly to travel to treatment centres. The majority of families (55%) had spent between pound 50-100 in the past week over and above pre-illness expenditure, with a further 18% spending more than pound 100. Many parents (mainly mothers) had either given up or reduced outside employment in order to care for their child and this was associated with further financial problems for 42.7% of families. Despite help from charities and government benefits for the majority of families, extra costs were associated with money worries for 68.3% of families.
Although families are offered timely information about their entitlement to benefits, financial problems are incurred by families of a child with cancer partly because legislation prevents benefits being claimed for the first 3 months of a child's illness - the time when expenses are still at their highest. Furthermore, because benefits are backdated only to the point at which the claim was made, families do not recoup all their costs. Waiving of the 84-day wait period for children undergoing chemotherapy and radiotherapy, and the introduction of weekly bridging payments while a Disability Living Allowance claim is being assessed, would ameliorate this problem and so improve the treatment experience for families.
目前针对儿童癌症的治疗方法已提高了生存率。然而,这是以家庭付出巨大代价为前提实现的,其中包括额外支出和收入损失等经济成本。这些额外成本对英国家庭的影响以及慈善机构和政府福利能在多大程度上缓解这些影响尚不清楚。
从英国儿童癌症研究小组的三个治疗中心招募了145名家长,他们填写了有关收入、支出、就业和经济支持的问卷。
家长的回答突出了主要与前往治疗中心相关的支出增加。大多数家庭(55%)在过去一周内的支出比患病前多出50至100英镑,另有18%的家庭支出超过100英镑。许多家长(主要是母亲)为了照顾孩子放弃或减少了外部工作,这给42.7%的家庭带来了进一步的经济问题。尽管大多数家庭得到了慈善机构和政府福利的帮助,但68.3%的家庭仍因额外费用而面临资金担忧。
尽管家庭及时获得了关于其应享福利的信息,但癌症患儿家庭仍会出现经济问题,部分原因是法律规定在孩子患病的前3个月内无法申领福利——而这正是费用仍处于最高水平的时期。此外,由于福利仅从申领之日起追溯,家庭无法收回所有成本。取消接受化疗和放疗儿童的84天等待期,并在评估残疾生活津贴申领期间引入每周过渡性付款,将改善这一问题,从而改善家庭的治疗体验。